|
|
THE TOP NEWS IN MARIJUANA LAW REFORM
Volume 22 • Issue 48 • December 05, 2019
|
|
|
Subjects who consumed cannabis daily "had about 50 percent lower odds of using illicit opioids every day [as] compared to cannabis non-users."
|
|
|
|
|
|
The FDA issued warning letters last week to 15 commercial providers of CBD products.
|
|
|
|
|
|
Authors reported, "Fourteen out of these 15 patients (93 percent) showed improvements equal to or above 30 percent in at least one symptom category."
|
|
|
|
The new guidance memo states, "[B]anks are no longer required to file suspicious activity reports (SAR) for customers solely because they are engaged in the growth or cultivation of hemp."
|
|
|
|
|
|
Investigators reported, "According to these and other published data, using THC-containing products with vitamin E acetate appears to be associated with EVALI."
|
|
|
|
Researchers concluded, "Our case suggests that state medical marijuana program THC/CBD products may provide relief for patients with refractory PSPS symptoms."
|
|
|
|
|
|
|
Of the 109 product samples submitted to the lab for analysis, nine tested positive for the presence of vitamin E acetate. By contrast, investigators said, "Every vaping product supplied to us by a regulated producer has been shown to be free of this particular additive."
|
|
|
|
Justices unanimously opined that a defendant possesses a presumed right to consume cannabis therapeutically unless there exists material evidence to show that prohibiting such use "is necessary and appropriate" to accomplish explicit sentencing goals.
|
|
|
|
|
|
12/03/19 5:56pm UTC
Study: Adult-Use Cannabis Access Associated with Decreased Sales of OTC Sleep Aids Details
12/03/19 5:27pm UTC
Adult-Use Marijuana Sales Begin in Michigan Details
12/02/19 4:17pm UTC
Marijuana Consumers Have a Lot to Be Thankful For Details
11/28/19 7:20pm UTC
|
|
|
|
|
|
|
Sent via ActionNetwork.org.
To update your email address, change your name or address, or to stop receiving emails from NORML, please click here.
|
|
|
|